`
`A scar-y movie, starring IL-11 | Science Translational Medicine
`
`Advertisement
`
`EDITORS' CHOICE
`
`
`FIBROSIS
`A scar-y movie, starring IL-11
`
`Kevin R. King
`+ See all authors and a¨liations
`
`Science Translational Medicine 29 Nov 2017:
`Vol. 9, Issue 418, eaar2443
`DOI: 10.1126/scitranslmed.aar2443
`
`Article
`
`Info & Metrics
`
`eLetters
`
`Abstract
`IL-11 is found to be a critical mediator of TGFβ1-induced scarring and ¦brosis in the heart and
`kidney.
`
`Fibrosis is considered a largely irreversible process leading to functional decline in a wide range of
`tissues. In the heart, ¦brosis impairs contractile function and electrical conduction causing
`progressive heart failure and fatal arrhythmias. It is also thought to impair cardiac regeneration.
`Transforming growth factor β1 (TGFβ1) is credited with fueling ¦brosis; however, it also has many
`non¦brotic roles that make it an unattractive target for direct inhibition. Therefore, Schafer and
`colleagues set out to identify ¦brosis-selective targets downstream of TGFβ1 signaling and
`discovered a surprising role for interleukin-11 (IL-11), a cytokine best known for its role in
`hematopoiesis.
`
`Log In ScienceMag.org
`The team began with a screen in which human ¦broblasts were stimulated with TGFβ1 to promote a
`Become a Member
`myo¦broblastic phenotype characterized by upregulation of ¦brosis-related genes and secretion of
`Singapore Exhibit 2002
`extracellular matrix (ECM), the hallmarks of ¦brosis. RNA-seq pro¦ling of the stimulated ¦broblasts
`Lassen v. Singapore et al.
`identi¦ed IL-11 as a gene highly induced by TGFβ1. In a genetic mouse model of cardiac ¦brosis,
`PGR2019-00053
`
`https://stm.sciencemag.org/content/9/418/eaar2443
`
`1/7
`
`
`
`11/12/2019
`
`A scar-y movie, starring IL-11 | Science Translational Medicine
`
`single cell RNA-seq analysis found the most common IL-11–expressing cell type to be ECM-
`producing ¦broblasts. The authors also found that ¦broblasts expressed the IL-11 receptor, IL-11RA,
`suggesting the possibility of an autocrine signaling loop. When stimulated with recombinant IL-11,
`¦broblasts increased ECM production, motility, contraction, and invasion. Moreover, IL-11 “ligand
`traps,” IL-11RA–neutralizing antibodies, or siRNA each decreased TGFβ1-induced ¦brosis in multiple
`assays.
`
`Surprisingly, stimulation of ¦broblasts with IL-11 increased ECM production without altering gene
`expression. The authors therefore designed a series of experiments that led them to propose a
`transcription-independent mechanism in which IL-11 interacts with IL-11RA shed from cellular
`surfaces and signals in trans to induce ECM production and ¦brosis. Exploration of the intracellular
`mechanism revealed that TGFβ1 activated the ERK kinase in an IL-11–dependent fashion and that
`blocking ERK reduced IL-11-induced ¦brotic phenotypes. In vivo, IL-11 was spontaneously increased
`in multiple preclinical models of cardiovascular and renal ¦brosis including angiotensin II infusion,
`transverse aortic constriction in the heart, and folate-induced kidney damage. Administration of
`recombinant IL-11 or expression of IL-11 from a collagen promoter in vivo caused widespread
`¦broblast activation, increased histologic evidence of ¦brosis, and end organ damage with cardiac
`and renal dysfunction. Meanwhile, mice de¦cient in the IL-11 receptor were protected from ¦brosis
`in the same models, pointing to its potential as a target for therapeutic inhibition.
`
`The mechanism by which IL-11 and its receptor signal in trans, and how this relates to ERK-
`dependent ¦brosis, remains unclear. Nevertheless, this study provides many lines of evidence that
`bring IL-11 into focus as a potential therapeutic target to inhibit ¦brosis; a fundamental
`pathophysiologic process a©icting nearly every tissue and underlying a wide range of clinically
`important diseases.
`
`Highlighted Article
`
`S. Schafer, S. Viswanathan, A. A. Widjaja, W.-W. Lim, A. Moreno-Moral, D. M. DeLaughter, B. Ng, G. Patone, K. Chow,
`E. Khin, J. Tan, S. P. Chothani, L. Ye, O. J. L. Rackham, N. S. J. Ko, N. E. Sahib, C. J. Pua, N. T. G. Zhen, C. Xie, M.
`Wang, H. Maatz, S. Lim, K. Saar, S. Blachut, E. Petretto, S. Schmidt, T. Putoczki, N. Guimarães-Camboa, H.
`Wakimoto, S. van Heesch, K. Sigmundsson, S. L. Lim, J. L. Soon, V. T. T. Chao, Y. L. Chua, T. E. Tan, S. M. Evans, Y. J.
`Loh, M. H. Jamal, K. K. Ong, K. C. Chua, B.-H. Ong, M. J. Chakaramakkil, J. G. Seidman, C. E. Seidman, N. Hubner, K.
`Y. K. Sin, S. A. Cook, IL11 is a crucial determinant of cardiovascular ¦brosis. Nature 10.1038/nature24676 (2017).
`
`Google Scholar
`
`Copyright © 2017, American Association for the Advancement of Science
`
`View Abstract
`
`Become a Member
`
`Log In ScienceMag.org
`
`Recommended articles from TrendMD
`
`https://stm.sciencemag.org/content/9/418/eaar2443
`
`2/7
`
`
`
`11/12/2019
`
`A scar-y movie, starring IL-11 | Science Translational Medicine
`
`The αvβ1 integrin plays a critical in vivo role in tissue
`fibrosis.
`
`Nilgun I Reed et al., Sci Transl Med, 2015
`
`Rapid skin improvement seen after treating
`systemic sclerosis patients with fresolimumab
`
`MedicalXpress, 2015
`
`Interleukin-11 is a therapeutic target in idiopathic
`pulmonary fibrosis
`
`Benjamin Ng et al., Sci Transl Med, 2019
`
`Papers of note in Nature 552 (7683)
`
`Annalisa M. VanHook, Sci Signal, 2017
`
`Lymphangiogenesis in kidney and lymph node
`mediates renal inflammation and fibrosis
`
`Guangchang Pei et al., Sci Adv, 2019
`
`Angiotensin Blockade—A Double-Edged Sword in
`Renal Failure
`
`Vipul Chitalia, Sci Transl Med, 2014
`
`Promising steps towards a treatment for pulmonary
`fibrosis
`
`MedicalXpress, 2019
`
`Airway transplantation of adipose stem cells
`protects against bleomycin-induced pulmonary
`fibrosis
`
`Pedro Llontop et al., Journal of Investigative
`Medicine, 2018
`
`TGF-beta1 induces IL-8 and MCP-1 through a
`connective tissue growth factor-independent
`pathway.
`
`Weier Qi et al., American Journal of Physiology -
`Renal Physiology, 2005
`
`Decreased Smad 7 expression contributes to
`cardiac fibrosis in the infarcted rat heart
`
`Baiqiu Wang et al., American Journal of Physiology
`- Heart and Circulatory Physiology, 2002
`
`Powered by
`
`Science Translational Medicine
`Vol 9, Issue 418
`29 November 2017
`
`Table of Contents
`
`ARTICLE TOOLS
`
`
`
`
`
`
` Request Permissions
`
` Citation tools
`
`
`
`
`
` Save to my folders
`
` Alerts
`
` Share
`
`Advertisement
`
`Become a Member
`
`Log In ScienceMag.org
`
`https://stm.sciencemag.org/content/9/418/eaar2443
`
`3/7
`
`